HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Effects of high doses of A-74273, a novel nonpeptidic and orally bioavailable renin inhibitor.

Abstract
Previous studies with peptidic renin inhibitors have shown that high intravenous (i.v.) doses can induce unexpectedly large decreases in blood pressure (BP) that appear to be independent of plasma renin inhibition. A-74273 represents a new class of potent and orally bioavailable nonpeptidic renin inhibitors. We evaluated the BP effects of this renin inhibitor administered orally (p.o.) or i.v. at high doses to conscious salt-depleted dogs. Administration of A-74273 at 30 and 60 mg/kg p.o. (n = 6 per dose) produced similar maximum reductions in BP (-40 +/- 4 vs. -46 +/- 5 mm Hg) despite the occurrence of greater plasma drug concentrations at the higher dose. Duration of hypotension, however, was increased (p < 0.05) from 9 h at 30 mg/kg to 18 h at 60 mg/kg. The initial depressor response to 10 and 30 mg/kg i.v. doses of A-74273 (n = 6 per dose) was comparable, although duration and overall BP response was greater at 30 mg/kg i.v. No BP responses to A-74273 were noted in salt-replete dogs (n = 5). The hypotension produced by 30 mg/kg p.o. A-74273 was completely reversed by norepinephrine (NE 5 micrograms/kg/min; n = 5) or isotonic saline (4 ml/min/kg, n = 5) infusion. These studies demonstrate that high doses of A-74273 result in predictable BP responses that are renin-dependent and reversible. Therefore, large decreases in BP with high doses is not an attribute common to all renin inhibitors but appears to be a function of the structural characteristics specific to a particular compound.
AuthorsK M Verburg, J S Polakowski, P J Kovar, V Klinghofer, J L Barlow, H H Stein, R A Mantei, A K Fung, S A Boyd, W R Baker
JournalJournal of cardiovascular pharmacology (J Cardiovasc Pharmacol) Vol. 21 Issue 1 Pg. 149-55 (Jan 1993) ISSN: 0160-2446 [Print] United States
PMID7678671 (Publication Type: Journal Article)
Chemical References
  • Amides
  • Morpholines
  • A 74273
  • Renin
  • Norepinephrine
Topics
  • Administration, Oral
  • Amides (administration & dosage, blood, pharmacology)
  • Animals
  • Biological Availability
  • Blood Pressure (drug effects)
  • Dogs
  • Heart Rate (drug effects)
  • Hypotension (chemically induced)
  • Male
  • Morpholines (administration & dosage, blood, pharmacology)
  • Norepinephrine (pharmacology)
  • Renin (antagonists & inhibitors, blood)
  • Vasoconstriction (drug effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: